| Literature DB >> 21829337 |
Tian Hong1, Jianhua Xing, Liwu Li, John J Tyson.
Abstract
The reciprocal differentiation of T helper 17 (T(H)17) cells and induced regulatory T (iT(reg)) cells plays a critical role in both the pathogenesis and resolution of diverse human inflammatory diseases. Although initial studies suggested a stable commitment to either the T(H)17 or the iT(reg) lineage, recent results reveal remarkable plasticity and heterogeneity, reflected in the capacity of differentiated effectors cells to be reprogrammed among T(H)17 and iT(reg) lineages and the intriguing phenomenon that a group of naïve precursor CD4(+) T cells can be programmed into phenotypically diverse populations by the same differentiation signal, transforming growth factor beta. To reconcile these observations, we have built a mathematical model of T(H)17/iT(reg) differentiation that exhibits four different stable steady states, governed by pitchfork bifurcations with certain degrees of broken symmetry. According to the model, a group of precursor cells with some small cell-to-cell variability can differentiate into phenotypically distinct subsets of cells, which exhibit distinct levels of the master transcription-factor regulators for the two T cell lineages. A dynamical control system with these properties is flexible enough to be steered down alternative pathways by polarizing signals, such as interleukin-6 and retinoic acid and it may be used by the immune system to generate functionally distinct effector cells in desired fractions in response to a range of differentiation signals. Additionally, the model suggests a quantitative explanation for the phenotype with high expression levels of both master regulators. This phenotype corresponds to a re-stabilized co-expressing state, appearing at a late stage of differentiation, rather than a bipotent precursor state observed under some other circumstances. Our simulations reconcile most published experimental observations and predict novel differentiation states as well as transitions among different phenotypes that have not yet been observed experimentally.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21829337 PMCID: PMC3145653 DOI: 10.1371/journal.pcbi.1002122
Source DB: PubMed Journal: PLoS Comput Biol ISSN: 1553-734X Impact factor: 4.475
Figure 1Induction of differentiation from naïve CD4+ T cells to TH17 and iTreg.
A population of antigen-activated naïve CD4+ T cells (white) can be induced by different types of cytokine micro-environment to produce corresponding differentiated cell populations. TH17 cells (red) express the RORγt transcription factor, and iTreg cells (green) express the Foxp3 transcription factor. Some cells (yellow) express both master regulators and may possess both regulatory and pro-inflammatory functions.
Figure 2Influence diagrams of the mathematical models.
A. Symmetrical model without intermediates. B. Symmetrical model with intermediates. C. Asymmetrical model with three input signals: TGF-β, ATRA, and IL-6.
Descriptions and basal values of parameters.
| Parameter name | Description | Basal value in symmetrical model without intermediates | Basal value in symmetrical model with intermediates | Basal value in model with broken symmetry |
|
| Relaxation rate of RORγt | 1 | 1 | 1 |
|
| Relaxation rate of Foxp3 | 1 | 1 | 1 |
|
| Steepness of sigmoidal function for RORγt | 5 | 5 | 7 |
|
| Steepness of sigmoidal function for Foxp3 | 5 | 5 | 5 |
|
| Basal activation state of RORγt | −0.8 | −0.8 | −0.84 |
|
| Basal activation state of Foxp3 | −0.8 | −0.8 | −0.92 |
|
| Weight of autoactivation of RORγt | 1.24 | 1.2 | 0.7 |
|
| Weight of inhibition on RORγt by Foxp3 | −0.4 | −0.4 | NA |
|
| Weight of autoactivation of Foxp3 | 1.24 | 1.2 | 1.28 |
|
| Weight of inhibition on Foxp3 by RORγt | −0.4 | −0.4 | −0.54 |
|
| Weight of activation on RORγt by TGF-β | 1.2 | NA | NA |
|
| Weight of activation on Foxp3 by TGF-β | 1.2 | NA | NA |
|
| Relaxation rate of unknown intermediate (UI) | NA | 1 | 1 |
|
| Relaxation rate of Smad | NA | 1 | 1 |
|
| Steepness of sigmoidal function for UI | NA | 10 | 12 |
|
| Steepness of sigmoidal function for Smad | NA | 10 | 20 |
|
| Basal activation state of UI | NA | −0.2 | −0.23 |
|
| Basal activation state of Smad | NA | −0.2 | −0.225 |
|
| Weight of activation on RORγt by UI | NA | 0.62 | 0.86 |
|
| Weight of activation on Foxp3 by Smad | NA | 0.62 | 0.68 |
|
| Weight of activation on UI by TGF-β | NA | 1.2 | 1 |
|
| Weight of activation on Smad by TGF-β | NA | 1.2 | 1 |
|
| Weight of inhibition on RORγt by ATRA | NA | NA | −0.04 |
|
| Weight of activation on Foxp3 by ATRA | NA | NA | 0.035 |
|
| Relaxation rate of IL-17 | NA | NA | 1 |
|
| Steepness of sigmoidal function for IL-17 | NA | NA | 30 |
|
| Basal activation state of IL-17 | NA | NA | −0.82 |
|
| Weight of activation on IL-17 by RORγt | NA | NA | 0.22 |
|
| Weight of inhibition on IL-17 by Foxp3 | NA | NA | −0.8 |
|
| Weight of activation on IL-17 by STAT3 | NA | NA | 0.6 |
|
| Weight of inhibition on IL-17 by ATRA | NA | NA | −0.1 |
|
| Relaxation rate of STAT3 | NA | NA | 0.1 |
|
| Steepness of sigmoidal function for STAT3 | NA | NA | 10 |
|
| Basal activation state of STAT3 | NA | NA | −0.4 |
|
| Weight of activation on RORγt by STAT3 | NA | NA | 0.2 |
|
| Weight of inhibition on Foxp3 by STAT3 | NA | NA | −0.1 |
|
| Weight of activation on STAT3 by IL-6 | NA | NA | 0.2 |
|
| Concentration of IL-6 | NA | NA | C |
|
| Concentration of ATRA | NA | NA | C |
|
| Concentration of TGF-β | C | C | C |
C: Values are specified in each simulation and might be changed at certain times during the simulation. These parameters are not subject to cell-to-cell variations.
Figure 3Phase plane analysis of the symmetrical model without intermediates.
X and Y axes: dimensionless quantities that represent the intracellular concentrations of master regulators Foxp3 and RORγt respectively. Value = 1 indicates the maximum intracellular concentration of the master regulator, and value = 0 indicates the absence of the master regulator. Red Line: nullcline for RORγt. Green line: nullcline for Foxp3. Steady states, at the intersections of red and green nullclines, are labeled as ‘u’ (unstable) or ‘s’ (stable). Magenta dashed line with arrow: trajectory of a time-course simulation. Semi-transparent red and green areas: the basins of attractions for RORγthighFoxp3low and RORγtlowFoxp3high states, respectively. A. Phase plane for the average cell with [TGF-β] = 0. Magenta circle: RORγlowFoxp3low steady state. B. Phase plane for the average cell with [TGF-β] = 0.5 units. Magenta circle is the location of the steady state in Panel A. C. Overlaid phase planes and trajectories for three cells adopting distinct fates. D. Simulation trajectories for a population of 30 cells on the plane of RORγt and Foxp3.
Figure 4Bifurcation diagrams and signal-response curves for three models.
Upper and middle panels: one-parameter bifurcation diagrams for the average cell. Steady state levels of RORγt and Foxp3 are plotted as functions of TGF-β concentration. Solid line: stable steady states. Dashed line: unstable steady states. Lower panels: signal-response curves. For each point on the abscissa (for [TGF-β] = constant), we simulate induced differentiation of a population of 1000 cells. Percentages of cells at the alternative steady states are plotted as functions of TGF-β concentration used for induction. Red line: RORγt-only cells. Green line: Foxp3-only cells. Yellow line: double-expressing cells. Blue marker: Foxp3-expressing cells. Magenta marker: IL-17 producing cells. A. Symmetrical model without intermediates. B. Symmetrical model with intermediates. C. Asymmetric model. Dotted vertical lines denote representative experimental levels of TGF-β.
Figure 5Effects of polarizing signals on the induced differentiation.
Simulation of the asymmetric model (Figure 1C). Upper and middle panels: one-parameter bifurcation diagrams for the average cell. RORγt and Foxp3 steady state levels are plotted as functions of TGF-β concentration. See the legend to Figure 3 for the interpretation of the curves. A. Cells treated with [IL-6] = 10 units together with the indicated amount of TGF-β. B. Cells treated with [ATRA] = 1.5 units together with the indicated amount of TGF-β. C. Cells treated with [IL-6] = 10 units and [ATRA] = 1.5 units together with the indicated amount of TGF-β.
Figure 6Reprogramming from iTreg to TH17 in the presence of TGF-β.
A. Time course trajectories of simulated reprogramming effects. 1 time unit≈1 h. [TGF-β] = 0 for t<10, and [TGF-β] = 0.28 for t>10. [IL-6] = 0 for t<80, and [IL-6] = 10 for t>80. At each time point, we plot the percentages of cells at the alternative steady states, using the same color scheme as in Figure 3. Left panel: no ATRA added. Right panel: 1.5 units of ATRA added together with TGF-β. B. Analysis of concentration dependencies for simulations described in Panel A. X axis: amount of IL-6 used for reprogramming. Y axis: amount of ATRA used for initial induction of differentiation. Percentages of cells at steady state are shown according to a color gradient. Left panel: percentage of Foxp3-expressing cells at steady state. Right panel: percentage of IL-17-producing cells at steady state.
Simulation results and comparisons with published experimental results.
| Experimental/simulation condition | TGF-β concentration | Simulation result | Evidence |
| Inducing differentiation from naïve CD4+ T cells with TGF-β alone | Intermediate | Three phenotypes in comparable fractions | Observed |
| Low-intermediate | Low concentration of TGF-β gives greater percentage of Foxp3 expressing cells than intermediate concentration. | Observed | |
| High | RORγt-only and double-expressing phenotypes in comparable fractions | Observed | |
| Low | Foxp3-only phenotype is the major differentiated phenotype | Prediction | |
| From low to high | Transition from Foxp3-only phenotype to RORγt-only and double-expressing phenotypes | Prediction | |
| From high to low | Transition from RORγt-only or double-expressing phenotype to Foxp3-only phenotype | Prediction | |
| Inducing differentiation from naïve CD4+ T cells with TGF-β and IL-6 | Intermediate | Mostly RORγt phenotype, with a fraction of cells producing IL-17 | Observed |
| High | RORγt (major fraction) and double-expressing (minor fraction) phenotypes | Observed | |
| Low-intermediate-high | Higher concentration of TGF-β inhibits IL-17 production | Observed in more extent | |
| Inducing differentiation from naïve CD4+ T cells with TGF-β and ATRA | Intermediate | More Foxp3 expressing cells than with TGF-β alone | Observed |
| Intermediate | Foxp3-only phenotype is the major differentiated phenotype | Prediction | |
| High | Double-expressing phenotype is the major differentiated phenotype | Prediction | |
| Inducing differentiation from naïve CD4+ T cells with TGF-β, IL-6 and ATRA | High | RORγt-only and double-expressing phenotypes in comparable fractions. IL-17 production is much lower than with TGF-β and IL-6 | Observed |
| Inducing differentiation from naïve CD4+ T cells to iTreg cells with TGF-β, and reprogramming the differentiated iTreg cells with IL-6 | Intermediate | Foxp3 expressing cells are reduced, and IL-17 producing cells appear in significant fraction. | Observed |
| Inducing differentiation from naïve CD4+ T cells to iTreg cells with TGF-β and ATRA, and reprogramming the iTreg cells with IL-6 | Intermediate | Foxp3 expressing cells are reduced, and no significant number of IL-17 producing cells can be observed. | Observed |
| Intermediate | Most cells are in ‘poised’ state at which RORγt expression is high, but no IL-17 is produced. | Prediction |